John M. Climaco - Apr 8, 2024 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher Downs, Attorney-in-Fact
Stock symbol
CNSP
Transactions as of
Apr 8, 2024
Transactions value $
$0
Form type
4
Date filed
4/10/2024, 09:50 PM
Previous filing
Feb 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNSP Option to purchase common stock Award +83K +21.09% 477K Apr 8, 2024 Common Stock 83K $0.26 Direct F1, F2
transaction CNSP Restricted Stock Units Award +83K +17.42% 560K Apr 8, 2024 Common Stock 83K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in the table vest in 36 equal monthly installments over three years.
F2 Issued in connection with the reporting person's employment with the Company.
F3 Each restricted stock unit represents a contingent right to receive one share of Company common stock.
F4 The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.